Skip to main content
Clinical Trials/CTRI/2024/06/068305
CTRI/2024/06/068305
Not yet recruiting
Phase 3

Evaluation of clinical efficacy of sub-gingivally delivered Propolis Nanoparticle as an adjunct to non-surgical periodontal therapy in patients with stage 2 and stage 3 periodontitis: a split mouth randomized controlled trial - NI

TPCTs Terna Dental college0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
TPCTs Terna Dental college
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
TPCTs Terna Dental college

Eligibility Criteria

Inclusion Criteria

  • 1\.Both male and female patients with stage 2 or stage 3 periodontitis in at least 2 teeth in contralateral quadrants.2\.Age group between 18\-60 years with good systemic health.3\. Minimum 20 teeth should be present in the mouth of patients.
  • 4\.Patients with no history of allergies.

Exclusion Criteria

  • 1\.Patients suffering from any known systemic
  • diseases.2\.Smokers and alcoholic patients.3 Pregnancy or lactating female patients.4\.Patients who have received surgical or nonsurgical periodontal therapy in last 3 months prior to the baseline visit.5\.•Patients who have allergic to propolis products.

Outcomes

Primary Outcomes

Not specified

Similar Trials